Unbalanced AI funding and human resources

AI around the world

Unbalanced AI funding and human resources

Warp Sciences has raised $215 million to build a lab that uses AI and robots to run chemical experiments. During the same period, American Express was reported to be cutting 5% of its workforce, and Colliers warned that a lack of AI talent could hinder growth in Europe. In a place where funding and expectations are high, a reshuffle of personnel and a shortage of personnel are occurring at the same time. What the articles we will read in this half-day have in common is the view that the difference between success and failure is less about how much money is invested in AI and more about how the investment goes through on-site verification and by whose hands it is run. Research in diagnosis, speech classification, and prediction also confronts readers with the differences between results under appropriate conditions and results in real environments.

Warp Sciences raises $215 million to build an AI-powered drug discovery lab (citybiz). According to BRIDGE, the company is a company that uses AI and robots to conduct chemical experiments for drug discovery, and the company raised funding through a Series A led by Lightspeed. At the Series A stage, more than $200 million was raised. The destination of the funds is also a point of interest. The aim is not only to develop software and models, but also to build labs to actually perform experiments and automate chemical experiments.

• Cell Therapy Weekly: AI Collaboration to Predict CAR-T Response and Toxicity RegMedNet
• AI speech model classifies dysarthria severity in real-world recordings Bioengineer.org
• AI skills gap threatens to stall Europe's AI growth, Colliers warns Data Centre Solutions
• What Happens When David Salle Lets AI into the Studio? Frieze
• AI system outperforms physicians on diagnostic accuracy in Microsoft study Medical Economics
• EdenCore showcases AI-powered fruit monitoring technology at FIRA USA Fruit Growers News
• Warp Sciences Raises $215M to Build AI-Powered Drug Discovery Labs citybiz

Full world overview →